Ctxr marketwatch
WebCTXR - Citius Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Monthly Draw Fullscreen Settings CTXR - Stock Price Chart CTXR [NASD] WebUEC Complete Uranium Energy Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Ctxr marketwatch
Did you know?
WebCTXR Complete Citius Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Web1 day ago · Market Cap $16.72M Shares Outstanding 17.24M Public Float 16.44M Beta 0.91 Rev. per Employee $113.10K P/E Ratio N/A EPS -$1.1270 Yield N/A Dividend N/A Ex-Dividend Date N/A Short Interest 663.77K...
WebJD.com stock price target cut to $45 from $62 at Susquehanna. Mar. 13, 2024 at 6:41 a.m. ET by Tomi Kilgore. WebJul 1, 2024 · Shares of Citius Pharmaceuticals ( CTXR -0.99%), a clinical-stage biopharmaceutical company, are getting beaten down today after the company released disappointing news regarding its lead...
WebSep 9, 2024 · CTXR - Citius Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 … WebCitius Pharmaceuticals Inc. on Wednesday said it filed for U.S. Food and Drug Administration approval of its lead product candidate denileukin diftitox, also known as I/Ontak, for the treatment of...
WebCTXR Citius Pharmaceuticals Inc. Profile MarketWatch Citius Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch. Citius …
WebCitius Pharmaceuticals, Inc. Common Stock (CTXR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. iowa hawkeyes vs purdueWeb20 hours ago · Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% 06/30/20-7:54AM EST Zacks. Other News for CTXR Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR) 04/04/23-11:25AM EST ... open alwaysWebMar 24, 2024 · Earnings for Citius Pharmaceuticals are expected to grow in the coming year, from ($0.11) to $0.96 per share. Citius Pharmaceuticals has not formally confirmed its … open a map crossword clueWebApr 4, 2024 · Earnings Summary. For their last quarter, Citius Pharmaceuticals (CTXR) reported earnings of -$0.04 per share. This reflects a breakeven earnings surprise. Look out for CTXR's next earnings ... openal usesWebThe 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 4.00. The … open a mail order accountWebCitius Pharmaceuticals Inc. Quarterly balance sheet by MarketWatch. View all CTXR assets, cash, debt, liabilities, shareholder equity and investments. open a mail storeWebCTXR 15Min Scalper's edition test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives … open a markhams account